emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
Published 3 weeks ago • 824 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
3:17
the problem with intel is they are doing so many things at once, says melius’ ben reitzes
-
0:29
is pharma the next big industry in india? raj shamani #shorts
-
3:48
jobless claims surge but labor costs fall
-
2:40
all-time highs for pharma stocks - here's names to trade now
-
5:04
goldman sachs' eric sheridan on why amazon is still a good name to own
-
42:27
big pharma - how much power do drug companies have? | dw documentary
-
3:56
summers: us higher education has lost its way
-
3:57
intermountain healthcare ceo marc harrison: producing drugs in high quantities at a low price | cnbc
-
5:00
aptargroup ceo: pharmaceutical consumer goods demand continues to be strong since covid
-
4:48
spotlight on us' leading affordable pharma player | know all about amneal pharma | digital
-
11:47
healthcare profit clampdowm: essential medicines to be sold at mrp | india business hours |cnbc tv18
-
1:01:48
why pharmaceuticals are so complicated in the u.s. | cnbc marathon
-
5:48
alkermes ceo: fundamental facts of pricing pharma | mad money | cnbc
-
0:59
alex denner adds ironwood pharma and medicines co. to best picks
-
2:24
tamil nadu based global pharma recalls eye drops from u.s market | digital | cnbc-tv18
-
0:59
why i will never invest in ipos
-
2:26
most therapeutic areas back to pre-pandemic levels, says medtronic ceo
-
0:53
how to get ready for shark tank india ft. vineeta singh | #shorts | sugar cosmetics
-
5:25
nestle ceo on the company's aimmune therapeutics acquisition
-
3:54
watch cnbc's full interview with one medical ceo